A Phase II Study to Investigate Lung Function With 2 Different Doses of Inhaled Glycopyrronium Taken With BFF Compared to BFF in Participants of 4 to Less Than 12 Years of Age With Asthma
Clinical trial NCT07525375 · RECRUITING
Trial details
- NCT number
- NCT07525375
- Sponsor
- AstraZeneca
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-04-14
- Primary completion
- 2029-05-23
- Enrollment
- 69
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.